Deidre Brock MP

Member of Parliament for Edinburgh North and Leith

UK Government must act to unlock off-patent drugs

Deidre Brock MP has called for the UK Government to help make cost effective, lifesaving drugs more readily available on the NHS.

The Edinburgh North and Leith MP is backing the Off-patent Drugs Bill which would make it easier for older drugs to be licensed and used for a secondary purpose.

Ms Brock said:-

"Drugs licensing is a reserved issue, but the process is flawed and failing patients. We need decisive action from the UK Government to bridge the gap when the market fails, and make sure these cheap, safe drugs are available to everyone who would benefit from them.

"I've stayed in London this Friday to show my support for the Off-patent Drugs Bill. A small change to UK drug licensing laws could make a big difference to the availability of low cost treatments on the NHS in Scotland.

"The UK Government must listen to thousands of patients and healthcare professionals, step in and commit to taking this legislation forward."

Notes to Editors

1. This includes drugs such as Tamoxifen, which is licensed as a breast cancer treatment, but not as a preventative measure, despite reducing the chance of women at high risk from developing the disease by about a third - Brief from Breast Cancer Now: http://breastcancernow.org/sites/default/files/public/150901_unlock_drugs_campaigner_guide_final.pdf

2. The Bill is supported by the Royal College of Surgeons in Edinburgh and a wide range of charities including Breast Cancer Now, Multiple Sclerosis Society, Alzheimer's Society and The Cure Parkinson's Trust.

3. The Off-patent Drugs Bill is a Private Member's Bill introduced by Nick Thomas-Symonds MP. Deidre Brock will attend the second reading debate and support the Bill on Friday November 6. http://services.parliament.uk/bills/2015-16/offpatentdrugs.html

CALL FOR ACTION TO UNLOCK OFF-PATENT DRUGS
Scotland Bill debated at Westminster

Comments

 
No comments yet
Already Registered? Login Here
Guest
Sunday, 21 October 2018

Tweets

Go to top